MedTrace Logo

Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors

NCT04456829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-01-15

No results posted yet for this study

Summary

To assess a resveratrol formula on improvement of skin conditions and inflammatory cytokines in blood

Conditions

  • Skin Conditions
  • Proinflammatory Cytokines

Interventions

DIETARY_SUPPLEMENT

Resveratrol drink

Subjects will consume a bottle of resveratrol drink for two months.

DIETARY_SUPPLEMENT

Placebo drink

Subjects will consume a bottle of placebo drink for two months.

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-17
Primary Completion
2020-11-10
Completion
2020-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04456829 on ClinicalTrials.gov